miR-5591-5p regulates the effect of ADSCs in repairing diabetic wound via targeting AGEs/AGER/JNK signaling axis

Cell Death Dis. 2018 May 1;9(5):566. doi: 10.1038/s41419-018-0615-9.

Abstract

Advanced glycation end products/advanced glycation end products receptor (AGEs/AGER) interaction triggers reactive oxygen species (ROS) generation and activates downstream signal pathways and induces apoptosis in endothelial progenitor cells. A number of studies have revealed the involvement of microRNAs (miRNAs) in regulating intracellular ROS production and apoptosis. However, few studies explore the role of miRNAs in regulating the effect of adipose tissue-derived stem cells (ADSCs) in repairing diabetic wound and the associated cellular mechanisms remain unclear. In this study, ADSCs were exposed to AGEs, then siRNA for AGER was transfected into ADSCs. We found that AGEs/AGER axis induced ROS generation and apoptosis in ADSCs. AGEs treatment downregulated miR-5591-5p in ADSCs, which directly targeted AGER. miR-5591-5p suppressed AGEs/AGER axis-mediated ROS generation and apoptosis in ADSCs in vitro. In addition, miR-5591-5p promoted cell survival and enhanced the ability of ADSCs for repairing cutaneous wound in vivo. Furthermore, we confirmed that c-jun kinase (JNK) signal was involved in the inhibitory effect of miR-5591-5p on AGEs/AGER axis-induced ROS generation and apoptosis in ADSCs. Thus, these results indicated that miR-5591-5p targeting AGEs/AGER/JNK signaling axis possibly regulates the effect of ADSCs in repairing diabetic wound.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adipose Tissue / metabolism*
  • Adipose Tissue / pathology
  • Animals
  • Antigens, Neoplasm / metabolism*
  • Apoptosis
  • Diabetes Mellitus, Experimental / metabolism*
  • Diabetes Mellitus, Experimental / pathology
  • Diabetes Mellitus, Experimental / therapy
  • Glycation End Products, Advanced / metabolism*
  • Heterografts
  • Humans
  • MAP Kinase Kinase 4 / metabolism*
  • Mice
  • Mice, Nude
  • MicroRNAs / metabolism*
  • Mitogen-Activated Protein Kinases / metabolism*
  • Reactive Oxygen Species / metabolism
  • Signal Transduction*
  • Stem Cell Transplantation
  • Stem Cells / metabolism*
  • Stem Cells / pathology
  • Wound Healing*

Substances

  • Antigens, Neoplasm
  • Glycation End Products, Advanced
  • MicroRNAs
  • Reactive Oxygen Species
  • MOK protein, human
  • Mitogen-Activated Protein Kinases
  • MAP Kinase Kinase 4